Definition of fungal rhinosinusitis. Otolaryngol Clin North Am 2000;33:227.
Practice guidelines for disease caused by Aspergillus. Clinical Infectious Dis 2000;30:696-709.
Fungal sinusitis. N Engl J Med 1997;337:254-59.
A new classification and diagnostic criteria for invasive fungal sinusitis. Arch Otolaryngol Head Neck Surg 1997;123(11):1181-88.
Fungal sinusitis. Am J Med Sci 1998;316(1): 39-45.
Chronic invasive fungal rhinosinusitis. Otolaryngol Clin North Am 2000;33(2):375-87.
N Engl J Med 2009;360:1870-84.
Invasive aspergillosis: Disease spectrum, treatment practices and outcomes. I3 aspergillus Study Group. Medicine 2000;79: 250-60.
In vitro activity of voriconazole against Aspergillus spp. and comparison with itraconazole and amphotericin B. J Antimicrob Chemother 1998; 42:91-94.
In vitro activities of amphotericin B, itraconazole and voriconazole against 150 clinical and environmental Aspergillus fumigatus isolates. J Antimicrob Chemother 1998; 42:389-92.
Comparison of the in vitro activity of voriconazole (UK-109,496), itraconazole and amphotericin B against clinical isolates of Aspergillus fumigatus. J Antimicrob Chemother 1998;42:531-33.
Activity of voriconazole (UK-109, 496) against clinical isolates of Aspergillus species and its effectiveness in an experimental model of invasive aspergillosis. Antimicrob Agents Chemother 1997;41:696-98.
UK-109,496, a novel, wide-spectrum triazole derivative for the treatment of fungal infections: Pharmacokinetics in man [abstract F78]. In program and abstract of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American society or Microbiology 1995:126.
Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clin Infect Dis 2002;34:563-71.
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002;347:408-15.
Voriconazole treatment for less-common, emerging, or refractory fungal infections. Clin Infect Dis 2003;36:1122-31.
Fulminant aspergillosis of the nose and paranasal sinuses: A new clinical entity. Laryngoscope 1980;90:748-54.
Percivall Pott: An 18th century neurosurgeon. J Neurosurg 1992;76(2):319-26.
Intracranial complications of sinusitis. Laryngoscope 1997;107(7):863-67.
An algorithmic approach to the diagnosis and management of invasive fungal rhinosinusitis in the immunocompromised patient. Otolaryngol Clin North Am 2000;33(2):323-34.
Invasive fungal sinusitis of isolated sphenoid sinus in immunocompetent subjects. Mycoses 2006;49(1):30-36.
Pediatric invasive fungal rhinosinusitis in immunocompromised children with cancer. Otolaryngol Head Neck Surg 2005;133(3):411-16.
Computed tomographic findings in patients with invasive fungal sinusitis. Arch Otolaryngol Head Neck Surg 2003;129(2):236-40.
Periantral soft-tissue infiltration and its relevance to the early detection of invasive fungal sinusitis: CT and MR findings. Am J Neuroradiol 1998;19(2): 321-25.
Histopathology of fungal rhinosinusitis. Otolaryngol Clin North Am 2000;33(2):251-76.
Impact of surgical treatment on paranasal fungal infections in bone marrow transplant patients. Otolaryngol Head Neck Surg 1997;116: 610-16.
Invasive fungal sinusitis: A 15-year review from a single institution. Am J Rhinol 2004;18(2):75-81.
Invasive sinus aspergillosis in apparently immunocompetent hosts. J Infect 1998;37:229-40.
Fungal rhinosinusitis: A categorization and definitional schema addressing current controversies. Laryngoscope 2009;119(9):1809-18.
Chronic invasive aspergillosis of the paranasal sinuses in immunocompetent hosts from Saudi Arabia. Am J Trop Med Hyg 2001;65:83-86.
Intracranial invasive aspergillosis; can a combined modality approach result in superior patient outcome?. Clin Rhinol 2008;1(1):1-5.
Chronic fungal sinusitis in apparently normal hosts. Medicine 1988;67:231-47.
Aspergillus flavus: Human pathogen, allergen and mycotoxin producer. Microbiology 2007;153:1677-92.
Aspergillus fumigatus: Principles of pathogenesis and host defense. Eukaryot Cell 2007;6:1953-63.
Density and molecular epidemiology of aspergillus in air and relationship to outbreaks of aspergillus infection. J Clin Microbiol 1999; 37:1752-57.
Census of aspergillus colonies in the air comparison between London, Paris, Lyon, Marseilles. Acta Allergol 1972;27:273-78.
Variations in fungal spores in the air during the last 10 years in belgium. Bull Mem Acad R Med Belg 1985;140:147-48.
Prevalence of airborne Aspergillus flavus in khartoum (Sudan) airspora with reference to dusty weather and inoculum survival in simulated summer conditions. Mycopathologia 1988;104:137-41.
Airborne viable, non-viable, and allergenic fungi in a rural agricultural area of India: A 2-year study at five outdoor sampling stations. Sci Total Environ 2004;326:123-41.
Lessons about the pathogenesis and management of aspergillosis from studies in chronic granulomatous disease. Trans Am Clin Climatol Assoc 2007; 118:175-85.
Effects of the Aspergillus fumigatus siderophore systems on the regulation of macrophage immune effector pathways and iron homeostasis. Immunobiology 2008;213:767-78.
Chronic invasive sinus aspergillosis in immunocompetent hosts: A geographic comparison. Mycopathologia 2010;170(6):403-10.
Postoperative responses of paranasal Aspergillus granuloma to itraconazole. Trans R Soc Trop Med Hyg 1992;86:93-94.
Nasosinusal fungal granuloma-clinical profile. Singapore Med J 1996;37:470-74.
Continual intracavitary administration of Amphotericin B as an adjunct in the treatment of Aspergillus brain abscess: Case report and review of the literature. Neurosurgery 1992;31:575-79.
Successful treatment of Invasive sinusitis with caspofungin and voriconazole. Ear Nose Throat J 2008;87:30-33.
Invasive sphenoidal aspergillosis: Successful treatment with sphenoidotomy and voriconazole. ORL J Otorhinol Relat Spec 2007;68:121-26.
Posaconazole for treatment of refractory invasive fungal disease. Mycoses 2006;49(Suppl 1):37-41.
Should Voriconazole be the primary therapy for Chronic invasive Sinus Aspergillosis. Clinical Rhinology: An International Journal 2011; 4(1): 21-26.
Rhinocerebral aspergillosis in patients undergoing bone marrow transplantation. Ann Otol Rhinol Laryngol 1994;103:306-10.
Rhinocerebral aspergillosis. Otolaryngol Head Neck Surg 1998;119:554-55.
Antifungal and surgical treatment of invasive aspergillosis: Review of 2121 published cases. Rev Infect Dis 1990; 12:1147-201.
Aspergillosis case fatality rate: systemic review of the literature. Clin Infect Dis 2001;32: 358-66.
The impact of culture isolation of Aspergillus species: Hospital-based survey of aspergillosis. Clin Infect Dis 2001;33:1824-33.
Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clin Infect Dis 2002;34:563-71.